Skip to main content


  • Wednesday, Jun 19th
    4:30 PM – 4:45 PM PT
    NK-mediated Protection Against Tumor Recurrence in CMV+ Bladder Cancer Patients Upon BCG Treatment
    Location: Salons 3-6
    Presenting Author: Berengere Salome, PharmD, PhD – Icahn School of Medicine at Mount Sinai, Genentech
    Immuno-oncology
  • Thursday, Jun 20th
    3:30 PM – 3:45 PM PT
    Peripheral Blood as a Source to Identify Candidate Neoantigens and Reactive TCRs
    Location: Salons 3-6
    Presenter: Andrea Garcia-Garijo – Vall d'Hebron Institute of Oncology
    Co-Author: Ricardo Pujol Borrell, MD, PhD – Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona
    Immuno-oncology
  • Thursday, Jun 20th
    3:45 PM – 4:00 PM PT
    Helios Limits CD8 T Cell Antitumor Capacity
    Location: Salons 3-6
    Presenting Author: Rosa M. Rubio – Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
    Immuno-oncology
  • Thursday, Jun 20th
    4:00 PM – 4:15 PM PT
    Secondary Inhibitory Signals on Human Kidney Microvascular Endothelium Confer Peripheral T Cell Tolerance: Insight from Checkpoint Inhibitor Toxicity
    Location: Salons 3-6
    Presenting Author: Kimberly Muczynski, MD, PhD – University of Washington
    Immuno-oncology
  • Thursday, Jun 20th
    4:30 PM – 4:45 PM PT
    HIV-associated Lung Cancer Exhibits an Immunoregulatory Tumor Microenvironment
    Location: Salons 3-6
    Presenting Author: Brinda Emu, MD – Yale University
    Immuno-oncology
  • Thursday, Jun 20th
    4:45 PM – 5:00 PM PT
    Exclusion of PD-1 from the Immune Synapse: A Novel Strategy to Modulate T Cell Function
    Location: Salons 3-6
    Presenter: Matthieu J. Paiola, PhD – Columbia University
    Immuno-oncology
  • Thursday, Jun 20th
    5:00 PM – 5:15 PM PT
    TMEM176B Is a Druggable Intrinsic Driver of Protumoral Th17 Lymphocytes
    Location: Salons 3-6
    Presenting Author: Marcelo Hill, MD, PhD – Institut Pasteur de Montevideo
    Immuno-oncology